Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients
Editorial Group: Cochrane Sexually Transmitted Diseases Group
Published Online: 16 MAR 2011
Assessed as up-to-date: 19 MAY 2010
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Le Cleach L, Trinquart L, Lebrun-Vignes B, Giraudeau B, Chosidow O. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD009036. DOI: 10.1002/14651858.CD009036.
- Publication Status: New
- Published Online: 16 MAR 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
We aim to assess the relative effectiveness and safety of competing oral antiviral drugs (ACV, FCV and VCV) prescribed to suppress recurrent genital herpes. In other words, we aim to assess the three possible pair-wise comparisons of each antiviral drug against each other.
In addition, we aim to assess whether the effectiveness depends on drug doses and regimen.